HU-210 je sintetički kanabinoid koji je prvi put sintetisan 1988. iz (1R,5S)-mirtenol]]a[2][3][4][5] HU-210 je 100 do 800 puta potentniji od prirodnog THC iz kanabisa i ima duže vreme dejstva.[6] HU-210 je (–)-1,1-dimetilheptil analog 11-hidroksi- Δ8- tetrahidrokanabinola.
^Mechoulam, R., Lander, N., Breuer, A., Zahalka, J. Synthesis of the Individual, Pharmacologically Distinct, Enantiomers of a Tetrahydrocannabinol Derivative. Tetrahedron: Asymmetry. 1990. Vol 1, No 5. pp 315-318.
^Mechoulam, R.; et al. (1988). „Enantiomeric cannabinoids: stereospecificity of psychotropic activity”. Experientia. 44 (9): 762—764. PMID3416993. S2CID19589995. doi:10.1007/BF01959156.CS1 одржавање: Експлицитна употреба et al. (веза)
^Little PJ, Compton DR, Mechoulam R, Martin BR. Stereochemical effects of 11-OH-Δ8-THC-dimethylheptyl in mice and dogs. Pharmacology, Biochemistry, and Behavior. 1989 Mar;32(3):661-666.
^Järbe, T.; Hiltunen, A.; Mechoulam, R. (1989). „Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons”. The Journal of Pharmacology and Experimental Therapeutics. 250 (3): 1000—1005. PMID2550611.
^Devane, W. A.; et al. (1992). „A novel probe for the cannabinoid receptor”. Journal of Medical Chemistry. 35 (11): 2065—2069. PMID1317925. doi:10.1021/jm00089a018.CS1 одржавање: Експлицитна употреба et al. (веза)
